Meyrick, Danielle
Gallyamov, Marat
Sabarimurugan, Shanthi
Falzone, Nadia
Lenzo, Nat
Article History
Accepted: 10 February 2021
First Online: 9 March 2021
Declarations
:
: No external funding was used in the preparation of this article.
: Danielle Meyrick, Marat Gallyamoa, Shanthi Sabarimurugan, Nadia Falzone and Nat Lenzo have no conflicts of interest that are directly relevant to the content of this article.
: The study was conducted in accordance with institutional ethical compliance for off-trial palliative treatment of patients with metastatic castration-resistant prostate cancer on a compassionate basis. From a regulatory perspective, this is provided under Category A of the Therapeutic Goods Administration Special Access Scheme.
: Written informed consent for publication was obtained from all patients.
: Not applicable.
: Data and material are available after request to the corresponding author.
: Not applicable.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Marat Gallyamov, Shanthi Sabarimurugan and Danielle Meyrick. The first draft of the manuscript was written by Marat Gallyamov and Danielle Meyrick, final editing performed by Nadia Falzone, Danielle Meyrick and Nat Lenzo and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.